Article
A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.
Pharmacogenetics and genomics - 1 Jan 2008
Ho Man Ki, Mwenifumbo Jill C, Zhao Bin, Gillam Elizabeth M J, Tyndale Rachel F
Abstract excerpt
OBJECTIVES: CYP2A6 is the main enzyme involved in nicotine metabolism in humans. We have identified a novel allele, CYP2A6*23 (2161C>T, R203C), in individuals of Black-African descent and investigated its impact on enzyme activity and association with smoking status. METHODS: Wild-type and variant enzymes containing amino acid changes R203C (CYP2A6*23), R203S (CYP2A6*16) and V365M (CYP2A6*17) were expressed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
